Cristian Castillo-Olea

Dr. Cristian Castillo-Olea

eVIDA Research Group, University of Deusto, 48007 Bilao, Spain
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2020 in Information
Verified
Journal Article
Open access
PDF file
ABAsma Baccouche
Asma Baccouche
Begonya Garcia ZapirainBegonya Garcia Zapirain
Begonya Garcia Zapirain
CCCristian Castillo-Olea
Cristian Castillo-Olea
Adel ElmaghrabyAdel Elmaghraby
Adel Elmaghraby
Heart diseases are highly ranked among the leading causes of mortality in the world. They have various types including vascular, ischemic, and hypertensive heart disease. A large number of medical features are reported for patients in the Electronic Health Records (EHR) that allow physicians to diagnose and monitor heart disease. We collected a dataset from Medica Norte Hospital in Mexico that includes 800 records and 141 indicators such as age, weight, glucose, blood pressure rate, and clinical symptoms. Distribution of the collected records is very unbalanced on the different types of heart disease, where 17% of records have hypertensive heart disease, 16% of records have ischemic heart disease, 7% of records have mixed heart disease, and 8% of records have valvular heart disease. Herein, we propose an ensemble-learning framework of different neural network models, and a method of aggregating random under-sampling. To improve the performance of the classification algorithms, we implement a data preprocessing step with features selection. Experiments were conducted with unidirectional and bidirectional neural network models and results showed that an ensemble classifier with a BiLSTM or BiGRU model with a CNN model had the best classification performance with accuracy and F1-score between 91% and 96% for the different types of heart disease. These results are competitive and promising for heart disease dataset. We showed that ensemble-learning framework based on deep models could overcome the problem of classifying an unbalanced heart disease dataset. Our proposed framework can lead to highly accurate models that are adapted for clinical real data and diagnosis use.

27 May 2019 in IEEE Transactions on Industrial Informatics
Verified
Journal Article
Closed access
DSDaniel Sierra-Sosa
Daniel Sierra-Sosa
Begonya Garcia ZapirainBegonya Garcia Zapirain
Begonya Garcia Zapirain
CCCristian Castillo-Olea
Cristian Castillo-Olea
IOIbon Oleagordia
Ibon Oleagordia
RNRoberto Nuño-Solinís
Roberto Nuño-Solinís
Adel ElmaghrabyAdel Elmaghraby
Adel Elmaghraby
The large-scale parallel computation that became available on the new generation of graphics processing units (GPUs) and on cloud-based services can be exploited for use in healthcare data analysis. Furthermore, computation workstations suited for deep learning are usually equipped with multiple GPUs allowing for workload distribution among multiple GPUs for larger datasets while exploiting parallelism in each GPU. In this paper, we utilize distributed and parallel computation techniques to efficiently analyze healthcare data using deep learning techniques. We demonstrate the scalability and computational benefits of this approach with a case study of longitudinal assessment of approximately 150 000 type 2 diabetic patients. Type 2 diabetes mellitus (T2DM) is the fourth case of mortality worldwide with rising prevalence. T2DM leads to adverse events such as acute myocardial infarction, major amputations, and avoidable hospitalizations. This paper aims to establish a relation between laboratory and medical assessment variables with the occurrence of the aforementioned adverse events and its prediction using machine learning techniques. We use a raw database provided by Basque Health Service, Spain, to conduct this study. This database contains 150 156 patients diagnosed with T2DM, from whom 321 laboratory and medical assessment variables recorded over four years are available. Predictions of adverse events on T2DM patients using both classical machine learning and deep learning techniques were performed and evaluated using accuracy, precision, recall and F1-score as metrics. The best performance for the prediction of acute myocardial infarction is obtained by linear discriminant analysis (LDA) and support vector machines (SVM) both balanced and weight models with an accuracy of 97%; hospital admission for avoidable causes best performance is obtained by LDA balanced and SVMs balanced both with an accuracy of 92%. For the prediction of the incidence of at least one adverse event, the model with the best performance is the recurrent neural network trained with a balanced dataset with an accuracy of 94.6%. The ability to perform and compare these experiments was possible through the use of a workstation with multi-GPUs. This setup allows for scalability to larger datasets. Such models are also cloud ready and can be deployed on similar architectures hosted on AWS for even larger datasets.

10 January 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
SPSebastian Patino
Sebastian Patino
DSDaniel Sierra-Sosa
Daniel Sierra-Sosa
Begonya Garcia ZapirainBegonya Garcia Zapirain
Begonya Garcia Zapirain
CCCristian Castillo-Olea
Cristian Castillo-Olea
Adel ElmaghrabyAdel Elmaghraby
Adel Elmaghraby
Colorectal cancer (CRC) is the second leading cause of cancer death in the world. This disease could begin as a non-cancerous polyp in the colon, when not treated in a timely manner, these polyps could induce cancer, and in turn, death. We propose a deep learning model for classifying colon polyps based on the Kudo’s classification schema, using basic colonoscopy equipment. We train a deep convolutional model with a private dataset from the University of Deusto with and without using a VGG model as a feature extractor, and compared the results. We obtained 83% of accuracy and 83% of F1-score after fine tuning our model with the VGG filter. These results show that deep learning algorithms are useful to develop computer-aided tools for early CRC detection, and suggest combining it with a polyp segmentation model for its use by specialists.

CCCristian Castillo-Olea
Cristian Castillo-Olea
Begonya Garcia ZapirainBegonya Garcia Zapirain
Begonya Garcia Zapirain
CZClemente Zuñiga
Clemente Zuñiga
The article presents a study based on timeline data analysis of the level of sarcopenia in older patients in Baja California, Mexico. Information was examined at the beginning of the study (first event), three months later (second event), and six months later (third event). Sarcopenia is defined as the loss of muscle mass quality and strength. The study was conducted with 166 patients. A total of 65% were women and 35% were men. The mean age of the enrolled patients was 77.24 years. The research included 99 variables that consider medical history, pharmacology, psychological tests, comorbidity (Charlson), functional capacity (Barthel and Lawton), undernourishment (mini nutritional assessment (MNA) validated test), as well as biochemical and socio-demographic data. Our aim was to evaluate the prevalence of the level of sarcopenia in a population of chronically ill patients assessed at the Tijuana General Hospital. We used machine learning techniques to assess and identify the determining variables to focus on the patients’ evolution. The following classifiers were used: Support Vector Machines, Linear Support Vector Machines, Radial Basis Function, Gaussian process, Decision Tree, Random Forest, multilayer perceptron, AdaBoost, Gaussian Naive Bayes, and Quadratic Discriminant Analysis. In order of importance, we found that the following variables determine the level of sarcopenia: Age, Systolic arterial hypertension, mini nutritional assessment (MNA), Number of chronic diseases, and Sodium. They are therefore considered relevant in the decision-making process of choosing treatment or prevention. Analysis of the relationship between the presence of the variables and the classifiers used to measure sarcopenia revealed that the Decision Tree classifier, with the Age, Systolic arterial hypertension, MNA, Number of chronic diseases, and Sodium variables, showed a precision of 0.864, accuracy of 0.831, and an F1 score of 0.900 in the first and second events. Precision of 0.867, accuracy of 0.825, and an F1 score of 0.867 were obtained in event three with the same variables. We can therefore conclude that the Decision Tree classifier yields the best results for the assessment of the determining variables and suggests that the study population’s sarcopenia did not change from moderate to severe.

CCCristian Castillo-Olea
Cristian Castillo-Olea
Begonya Garcia ZapirainBegonya Garcia Zapirain
Begonya Garcia Zapirain
CLChristian Carballo Lozano
Christian Carballo Lozano
CZClemente Zuñiga
Clemente Zuñiga
This paper presents a study based on data analysis of the sarcopenia level in older adults. Sarcopenia is a prevalent pathology in adults of around 50 years of age, whereby the muscle mass decreases by 1 to 2% a year, and muscle strength experiences an annual decrease of 1.5% between 50 and 60 years of age, subsequently increasing by 3% each year. The World Health Organisation estimates that 5–13% of individuals of between 60 and 70 years of age and 11–50% of persons of 80 years of age or over have sarcopenia. This study was conducted with 166 patients and 99 variables. Demographic data was compiled including age, gender, place of residence, schooling, marital status, level of education, income, profession, and financial support from the State of Baja California, and biochemical parameters such as glycemia, cholesterolemia, and triglyceridemia were determined. A total of 166 patients took part in the study, with an average age of 77.24 years. The purpose of the study was to provide an automatic classifier of sarcopenia level in older adults using artificial intelligence in addition to identifying the weight of each variable used in the study. We used machine learning techniques in this work, in which 10 classifiers were employed to assess the variables and determine which would provide the best results, namely, Nearest Neighbors (3), Linear SVM (Support Vector Machines) (C = 0.025), RBF (Radial Basis Function) SVM (gamma = 2, C = 1), Gaussian Process (RBF (1.0)), Decision Tree (max_depth = 3), Random Forest (max_depth=3, n_estimators = 10), MPL (Multilayer Perceptron) (alpha = 1), AdaBoost, Gaussian Naive Bayes, and QDA (Quadratic Discriminant Analysis). Feature selection determined by the mean for the variable ranking suggests that Age, Systolic Arterial Hypertension (HAS), Mini Nutritional Assessment (MNA), Number of chronic diseases (ECNumber), and Sodium are the five most important variables in determining the sarcopenia level, and are thus of great importance prior to establishing any treatment or preventive measure. Analysis of the relationships existing between the presence of the variables and classifiers used in moderate and severe sarcopenia revealed that the sarcopenia level using the RBF SVM classifier with Age, HAS, MNA, ECNumber, and Sodium variables has 82′5 accuracy, a 90′2 F1, and 82′8 precision.

24 November 2021 in Information
Verified
Journal Article
Open access
PDF file
CCCristian Castillo-Olea
Cristian Castillo-Olea
RCRoberto Conte-Galván
Roberto Conte-Galván
CZClemente Zuñiga
Clemente Zuñiga
ASAlexandra Siono
Alexandra Siono
AHAngelica Huerta
Angelica Huerta
EOEric Ortiz
Eric Ortiz
Background: The current pandemic caused by SARS-CoV-2 is an acute illness of global concern. SARS-CoV-2 is an infectious disease caused by a recently discovered coronavirus. Most people who get sick from COVID-19 experience either mild, moderate, or severe symptoms. In order to help make quick decisions regarding treatment and isolation needs, it is useful to determine which significant variables indicate infection cases in the population served by the Tijuana General Hospital (Hospital General de Tijuana). An Artificial Intelligence (Machine Learning) mathematical model was developed in order to identify early-stage significant variables in COVID-19 patients. Methods: The individual characteristics of the study subjects included age, gender, age group, symptoms, comorbidities, diagnosis, and outcomes. A mathematical model that uses supervised learning algorithms, allowing the identification of the significant variables that predict the diagnosis of COVID-19 with high precision, was developed. Results: Automatic algorithms were used to analyze the data: for Systolic Arterial Hypertension (SAH), the Logistic Regression algorithm showed results of 91.0% in area under ROC (AUC), 80% accuracy (CA), 80% F1 and 80% Recall, and 80.1% precision for the selected variables, while for Diabetes Mellitus (DM) with the Logistic Regression algorithm it obtained 91.2% AUC, 89.2% accuracy, 88.8% F1, 89.7% precision, and 89.2% recall for the selected variables. The neural network algorithm showed better results for patients with Obesity, obtaining 83.4% AUC, 91.4% accuracy, 89.9% F1, 90.6% precision, and 91.4% recall. Conclusions: Statistical analyses revealed that the significant predictive symptoms in patients with SAH, DM, and Obesity were more substantial in fatigue and myalgias/arthralgias. In contrast, the third dominant symptom in people with SAH and DM was odynophagia.